1. Extracellular NAD+ response to post-hepatectomy liver failure: bridging preclinical and clinical findings
- Author
-
Can Kamali, Philipp Brunnbauer, Kaan Kamali, Al-Hussein Ahmed Saqr, Alexander Arnold, Gulcin Harman Kamali, Julia Babigian, Eriselda Keshi, Raphael Mohr, Matthäus Felsenstein, Simon Moosburner, Karl-Herbert Hillebrandt, Jasmin Bartels, Igor Maximilian Sauer, Frank Tacke, Moritz Schmelzle, Johann Pratschke, and Felix Krenzien
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Abstract Liver fibrosis progressing to cirrhosis is a major risk factor for liver cancer, impacting surgical treatment and survival. Our study focuses on the role of extracellular nicotinamide adenine dinucleotide (eNAD+) in liver fibrosis, analyzing liver disease patients undergoing surgery. Additionally, we explore NAD+’s therapeutic potential in a mouse model of extended liver resection and in vitro using 3D hepatocyte spheroids. eNAD+ correlated with aspartate transaminase (AST) and bilirubin after liver resection (AST: r = 0.2828, p = 0.0087; Bilirubin: r = 0.2584, p = 0.0176). Concordantly, post-hepatectomy liver failure (PHLF) was associated with higher eNAD+ peaks (n = 10; p = 0.0063). Post-operative eNAD+ levels decreased significantly (p
- Published
- 2024
- Full Text
- View/download PDF